Article Sidebar
Main Article Content
Abstract
Since the start of the COVID-19 pandemic, attempts have been made to provide acquired immunity against COVID-19. Monitoring and evaluating the efficacy and safety of the COVID-19 vaccine is an important process that must always be carried out in order to optimize the control of the spread of COVID-19 infection. This study aimed to provide an overview of the status of COVID-19 vaccination in patients infected with COVID-19 at the Royal Prima General Hospital, Medan, Indonesia. This study was a descriptive observational study. A total of 100 subjects participated in this study. Data analysis was performed using SPSS version 25 in a univariate manner. The majority of patients who have been vaccinated against COVID-19 only experience mild symptoms of COVID-19. The majority of vaccine brands used by confirmed COVID-19 patients are Sinovac. The majority of patients who have received 2 doses of vaccination are still at risk of being infected with COVID-19. The majority of patients who received the COVID-19 vaccination experienced a low clinical degree when infected with COVID-19.
Keywords
Article Details
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
